Long-term Outcomes for Acute Myeloid Leukemia Patients

  • End date
    Dec 23, 2022
  • participants needed
  • sponsor
    Gruppo Italiano Malattie EMatologiche dell'Adulto
Updated on 23 January 2021
Francesca Tartaglia
Primary Contact
U.O. di Ematologia - Casa Sollievo della Sofferenza (0.0 mi away) Contact
+42 other location
acute promyelocytic leukemia
blast cells


This international observational study aims at examining the patterns of health-related quality of life differences between long-term acute myeloid leukemia patients and their healthy peers from the general population.

Condition Acute myeloid leukemia, Acute Myelogenous Leukemia (AML), acute myelogenous leukemia, anll, acute myeloblastic leukemia
Treatment Questionnaire
Clinical Study IdentifierNCT03755856
SponsorGruppo Italiano Malattie EMatologiche dell'Adulto
Last Modified on23 January 2021


Yes No Not Sure

Inclusion Criteria

Diagnosis of all subtypes of de novo AML, according to WHO criteria (at least 20% blasts in the bone marrow), except acute promyelocytic leukemia (APL)
Age at AML diagnosis 18 years
Date of AML diagnosis at least 5 years before study enrollment
AML-free status at study enrollment
Written informed consent provided

Exclusion Criteria

Major cognitive deficit or psychiatric problems hampering a self-reported evaluation
Not speaking and reading the language of the participating country
More than 75 years at the time of study enrollment
Receiving any active treatment for AML at the time of study enrollment
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note